Friday, July 10, 2026

pharma · Anorectal Disorder · Localized Primary Osteoarthritis of Both Hips (Diagnosis)

Chia Tai Tianqing

Chia Tai Tianqing clinical programs — 11 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Lianyungang, CN HQ
366 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Lianyungang, CN
Employees
366
Programs
11
Drugs
15
Patents
0
Intelligence · Clinical Programs

Chia Tai Tianqing projects

11 ClinicalTrials.gov programs sponsored by Chia Tai Tianqing.

Chia Tai Tianqing has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Gum chewing

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Recovery of Bowel Function, Due to Gum Chewing

    phase 3 other active

    1 trial
  2. Lidocaine spray

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Uterine Bleeding

    phase 3 small molecule completed

    1 trial
  3. Lidocaine spray

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Uterine Cervical Dysplasia

    phase 3 other completed

    1 trial
  4. Mevac-A vaccine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    HAV

    phase 3 mab completed

    1 trial
  5. Dexamethasone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Localized Primary Osteoarthritis of Both Hips (Diagnosis)

    approved small molecule active

    1 trial
  6. Hepatitis B vaccine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Hepatitis B Vaccination, HIV

    approved mab active

    1 trial
  7. Topiramate

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Alcohol Dependence

    approved small molecule active

    1 trial
  8. risperidone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Neuroleptic-Induced Tardive Dyskinesia

    approved small molecule completed

    1 trial
  9. Aescin in Horse Chestnut

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Anorectal Disorder

    small molecule active

    1 trial
  10. Triferdine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Pregnancy Related

    other completed

    1 trial
  11. placebo

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    PCOS- Polycystic Ovary Syndrome

    other active

    1 trial

Frequently asked questions

How many clinical projects does Chia Tai Tianqing have?

11 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.